Has Syed Muhammed Bilal Naqvi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $76,827 in general payments to Syed Muhammed Bilal Naqvi, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Syed Muhammed Bilal Naqvi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Syed Muhammed Bilal Naqvi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Syed Muhammed Bilal Naqvi, MD

Hematology & Oncology · Woodbury, MNNPI 1598865818

Payments from drug & device makers

$76,827in general payments, 2019–2025

Across 11 payments — averaging $6984.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Grifols Therapeutics LLC$59K
Merck$17K
Steris Corporation$166
E.r. Squibb & Sons, L.L.C.$23
Gilead$12

What the payments were for

Food & beverage$16683%
Education$3517%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Grifols Therapeutics LLC	6	$59,241
Merck	2	$17,384
Steris Corporation	1	$166
E.r. Squibb & Sons, L.L.C.	1	$23
Gilead	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRUFREEZE$166

How this compares

$76,827 in reported general payments places this provider in the 65th percentile of 193 hematology & oncology providers in Minnesota.

See all hematology & oncology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$228,176

Medicare patients

256

Services billed

6,691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RevlimidLenalidomide	39	$660,175
PromactaEltrombopag Olamine	14	$237,201
ImbruvicaIbrutinib	11	$175,165
VenclextaVenetoclax	13	$128,189
Abiraterone Acetate	17	$60,313
Anastrozole	62	$993
Ondansetron Hcl	33	$607
Prochlorperazine Maleate	48	$572
Hydroxyurea	25	$570
Dexamethasone	69	$481
Acyclovir	15	$261
Pantoprazole Sodium	20	$257
Prednisone	35	$133
Levofloxacin	13	$43

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Woodbury

Girum LemmaWoodbury$152K
Karin ArmstrongWoodbury$79K
Shilpa GuptaMinneapolis$16.3M
Yucai WangRochester$8.2M
Daniel AndersonSaint Paul$7.3M
Timothy LarsonMinneapolis$7.2M
Yan JiSaint Paul$6.3M
Manish PatelBloomington$6.2M
Samith KochuparambilMinneapolis$3.3M
Thomas AmatrudaFridley$3.3M

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →